Wedbush Expects A Better Q2 For Cutera (CUTR)

According to a recent report, Wedbush expects Cutera CUTR to make a big improvement after a terrible quarter. In the report, Wedbush said, "CUTR expects Q2 revenues to show growth on both a sequential and year/year basis. This would mark CUTR's best top-line growth in more than two years. North American ops have picked up momentum, Japan is stabilizing, and new products kick in significantly in Q2." Cutera closed yesterday at $8.88.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingscuteraHealth CareHealth Care EquipmentWedbush
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!